The Effect of Rsedronate and Denosumab on Periprosthetic Bone Remodeling Following Total Hip Arthroplasty

Trial Profile

The Effect of Rsedronate and Denosumab on Periprosthetic Bone Remodeling Following Total Hip Arthroplasty

Recruiting
Phase of Trial: Phase III

Latest Information Update: 22 Jun 2016

At a glance

  • Drugs Denosumab (Primary) ; Risedronic acid
  • Indications Osteoarthritis
  • Focus Therapeutic Use
  • Most Recent Events

    • 21 Jun 2016 Status changed from not yet recruiting to recruiting.
    • 27 Nov 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top